![John Castle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Castle
Directeur Technique/Scientifique/R&D chez
MONTE ROSA THERAPEUTICS, INC.
Profil
John Castle is currently Chief Data & Information Officer at Monte Rosa Therapeutics, Inc. Formerly, Dr. Castle was Associate Vice President-Translational Medicine at Agenus, Inc. from 2017 to 2020, Chief Scientific Officer at Achilles Therapeutics UK Ltd. from 2017 to 2018, Director-Computational Medicine at BioNTech SE from 2009 to 2014, Associate Director at Rosetta Inpharmatics LLC, Director at Encompass Northwest, Director at Cadence Biomedical, Inc., and Director-Biomark Development Center at The Johannes Gutenberg University of Mainz.
Education includes a doctorate from the University of Washington, undergraduate degrees from William Marsh Rice University and Massachusetts Institute of Technology, a doctorate from Massachusetts Institute of Technology, and an MBA from Harvard Business School.
Postes actifs de John Castle
| Sociétés | Poste | Début |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de John Castle
| Sociétés | Poste | Fin |
|---|---|---|
| AGENUS INC. | Corporate Officer/Principal | 01/04/2020 |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Directeur Technique/Scientifique/R&D | 01/01/2018 |
| BIONTECH SE | Corporate Officer/Principal | 01/11/2014 |
The Johannes Gutenberg University of Mainz
 The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Rosetta Inpharmatics LLC
 Rosetta Inpharmatics LLC BiotechnologyHealth Technology Develops and implements drug discovery technology | Corporate Officer/Principal | - |
Formation de John Castle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Develops and implements drug discovery technology | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Johannes Gutenberg University of Mainz
The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
Encompass Northwest
 Encompass Northwest Services to the Health IndustryHealth Services Provides individual and family social services and programs | Health Services |
Cadence Biomedical, Inc.
 Cadence Biomedical, Inc. Medical DistributorsDistribution Services Provides medical devices for mobility impairments | Distribution Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
